Purac Biochem BV
USPTO PatentsView assignee record - 121 granted patents across 57 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture).
The verdict
According to USPTO PatentsView, Purac ranks #3,123 of 49,997 tracked US assignees by granted-patent volume, with 121 patents across 57 technology areas.
- #3,123
- of 49,997 US assignees by volume
- Top 6%
- by Innovation Score (55.9/100)
- 16.7
- avg claims per patent
- -7%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R3123 · Foreign Corporation #3,123 · 121 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL
- GRANTS-MID 121 grants
- TOP-DECILE #3,123/49,997
- PHOTO-FINISH GlaxoSmithKline
- CPC-WIDE C12P · 57 areas
- INNOV-PAR 55.9/100
- CLAIMS-RICH 16.7 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-FLAT -7% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: GlaxoSmithKline LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Purac’s 55.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Purac
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Ndsu Research… · near
Ndsu Research… · near
56 score
- NOK · near
NOK · near
56 score
- Purac Biochem BV · this assignee
Purac Biochem BV · this assignee
56 score
- UNIVERSITÉ D'aix-mar… · near
UNIVERSITÉ D'aix-mar… · near
56 score
- Hyundai Steel · near
Hyundai Steel · near
56 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Purac's Innovation Score is 55.9/100 (top 6% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Purac?
Each dot is one of Purac’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Purac’s own 16.7 claims/patent is ABOVE the 11.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
How Purac's grant cadence moved
Between 2020–2024, Purac Biochem BV received 57 grants versus 61 in 2015–2019 (-7% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2018 at 21 grants and bottomed in 2023 at 4. Lead class C12P accounts for 38% of the portfolio across 57 subclasses. Volume neighbours: GlaxoSmithKline LLC (#3,119) and Shutterfly, LLC (#3,127).
Purac's three-year grant acceleration
From 2019–2021 to 2022–2024, Purac Biochem BV moved from 42 to 27 grants (0.64x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,328. See the growth leaderboard.
Who files at Purac's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Glaxosmithkline
GlaxoSmithKline LLC
121 patents
- Hefei BOE Display…
Hefei BOE Display Technology Co., Ltd.
121 patents
- Institute of Auto…
Institute of Automation, Chinese Academy of Sciences
121 patents
- Landscape Forms
Landscape Forms, Inc.
121 patents
- Shinkawa
Shinkawa Ltd.
121 patents
- Sunrise Memory
Sunrise Memory Corporation
121 patents
- Shukla Medical
Shukla Medical
121 patents
- Shutterfly
Shutterfly, LLC
121 patents
- Purac Biochem BV ◀
Purac Biochem BV
121 patents
What this shows Purac holds 121 patents at rank #3,123, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Purac
By rank, the assignees closest to #3,123 in granted patent volume.
- GlaxoSmithKline LLC #3,119 · 121 patents
- Hefei BOE Display Technology Co., Ltd. #3,120 · 121 patents
- Institute of Automation, Chinese Academy of Sciences #3,121 · 121 patents
- Landscape Forms, Inc. #3,122 · 121 patents
- Shinkawa Ltd. #3,124 · 121 patents
- Sunrise Memory Corporation #3,125 · 121 patents
- Shukla Medical #3,126 · 121 patents
- Shutterfly, LLC #3,127 · 121 patents
Leaders in C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…)
Other assignees with the most granted patents in Purac's primary technology class.
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Purac, neither rank-band nor same-CPC leaders (those blocks stay above). In C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…), Purac ranks #27 of 1,268 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (56 here).
Similar claim depth
Nearest assignees by average claims per patent (16.7 here).
Purac's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
56 Top 6% higher than 94% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 6 | 5.0% |
| 2016 | 9 | 7.4% |
| 2017 | 13 | 10.7% |
| 2018 | 21 | 17.4% |
| 2019 | 12 | 9.9% |
| 2020 | 19 | 15.7% |
| 2021 | 11 | 9.1% |
| 2022 | 13 | 10.7% |
| 2023 | 4 | 3.3% |
| 2024 | 10 | 8.3% |
| 2025partial year | 3 | 2.5% |
Which technologies does Purac Biochem BV patent most?
Top 15 of 57 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Purac Biochem BV's patent record in context - here's where to go next.
- Purac Biochem BV's lead technology class is C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture), 38% of its portfolio - see every assignee active in that class. Explore C12P
- Ranked #3,123 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Purac Biochem BV against GlaxoSmithKline LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 55.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.